GP122 Is treatment with atropine 0.01% eyedrops safe to prevent the progression of childhood myopia? | Archives of Disease in Childhood

Subscribe
Log In More

Log in via Institution
Log in via OpenAthens
Log in via RCPCH

Log in using your username and password
For personal accounts OR managers of institutional accounts

Username *

Password *

Forgot your log in details?Register a new account?
Forgot your user name or password?
Basket
Search More

Search for this keyword

Advanced search

Article info

Abstracts

GP122 Is treatment with atropine 0.01% eyedrops safe to prevent the progression of childhood myopia?

Free

Authors

Jose Manuel Siurana 1Fundacio Hospital de Nens, Barcelona, Spain 2Autonomous University, Barcelona, Spain PubMed articles Google scholar articles
Georges Akel 1Fundacio Hospital de Nens, Barcelona, Spain PubMed articles Google scholar articles
Lluis Cavero 1Fundacio Hospital de Nens, Barcelona, Spain PubMed articles Google scholar articles
Anna Mones 1Fundacio Hospital de Nens, Barcelona, Spain PubMed articles Google scholar articles
Ezequiel Anabalon 1Fundacio Hospital de Nens, Barcelona, Spain PubMed articles Google scholar articles
Paula Sol Ventura 1Fundacio Hospital de Nens, Barcelona, Spain PubMed articles Google scholar articles

Citation

Siurana JM, Akel G, Cavero L, et al

GP122 Is treatment with atropine 0.01% eyedrops safe to prevent the progression of childhood myopia?

Archives of Disease in Childhood 2019;104:A80.

Publication history

First published June 12, 2019.

Online issue publication

May 06, 2021

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

Copyright information

© Author(s) (or their employer(s)) 2019. No commercial re-use. See rights and permissions. Published by BMJ.